Indivior Share Discussion Threads

[the canadian mounted] 10/4/2019 10:59

Lovely rebound coming!

[the grumpy old men] 10/4/2019 10:57

Price (GBX) 28.09 Var % (+/-) -73.49% (Down -77.86)

[rafieh] 10/4/2019 10:57

Yes, but check out the drop in their market cap in British Pounds. A few billions!

[the grumpy old men] 10/4/2019 10:54

Reckitt Benckiser
5,997 -6.41%

[dmf] 10/4/2019 10:53

15p by market close

[the canadian mounted] 10/4/2019 10:50

Only way is up!

[rafieh] 10/4/2019 10:48

Reckitt Benckiser have lost much more of their market cap value today than the entire Indivior market cap!

[buywell3] 10/4/2019 10:46

27M now traded so far today

The drop resumes

I expect another 13M before close

[this_time_its_different] 10/4/2019 10:45

strong buy, litigation is fake news, they will appeal and win.

[letmepass] 10/4/2019 10:45

Only loser is you.. 20p coming and administration

[sunnybeachboy] 10/4/2019 10:44

I totally agree with your post Buywell.

[rzbrdbe] 10/4/2019 10:40

Indv has always been un-investible because of the litigation hanging over it. Investors have only themselves to blame for not reading Indivior's accounts.

The company has been very clear about the possibility of an adverse judgement in note 20 of its latest 2018 accounts (see below). It has carried a provision of $438m for many years, being its estimated costs of any resultant litigation (costs to be shared with Reckitt who have set aside a similar amount), but the political climate has now changed. Yes, you could argue that the 3bn sought by the DOJ is over egged but if 3bn is the outcome then the statement in note 20 of the accounts will become fact: "the Group would not continue in business without taking further necessary measures to reduce its cost base and improve its cash flow" and shareholders equity would be wiped out.
Shame, because the company appears to have been doing the right thing since separating from Reckitt by developing the implantable sublocade product, possibly a viable new addition to a solution for the US opioid crisis. Reckitt's management clearly saw this issue too hot to handle in 2014 (they are still on the hook for half, hence the decline of 10% in share price).


Indv is still un-investible

Note 20: "The Group carries a provision for investigative and antitrust litigation matters of $438m. Substantially all of the provision relates to the U.S. Department of Justice investigation. The Group is in advanced discussions with the Department of Justice about a possible resolution to its investigations, although it cannot predict with any certainty whether, when, or at what cost it will reach an ultimate resolution. Although the total amount of the provision has not changed, the classification between current and non-current has changed due to a shift in management’s best estimate of the timing of payments.
In the event the final settlement amount of the DOJ matter is materially higher than the provision or is required to be paid over a shorter period of time, and the Group is further adversely impacted by higher than expected loss of revenue following the ‘at-risk’; launch of generic buprenorphine/naloxone sublingual film products or the failure for new products to meet revenue growth expectations, the Group would not continue in business without taking further necessary measures to reduce its cost base and improve its cash flow"

[dealy] 10/4/2019 10:38

DoJ saying to business: one foot wrong and we will take the whole company.

[zen12] 10/4/2019 10:38

Travels down quickly but will equally bounce up swift. On US open should get more news on this possibly in afternoon.

[mrjackpot777] 10/4/2019 10:34

Everytime this has got smashed

check out time it reversed, it's always around 10.30-10.45.

Don't believe look at daily chart on spike down.

[letmepass] 10/4/2019 10:34

Just pit biggest short on

[mrjackpot777] 10/4/2019 10:32

Took shares average 27.67.

cash 3 times the share price

tight stop

Mr J

[the canadian mounted] 10/4/2019 10:31

This will rebound sharply!

[the grumpy old men] 10/4/2019 10:29

Indivior's indictment adds "further uncertainty" to Reckitt Benckiser's outlook, said RBC Capital Markets.

TRUST RB WILL ALMOST CERTAINLY CONTRIBUTE MORE TO THE LEGAL COSTS

[urbanvoltage] 10/4/2019 10:29

Good time for a significant share buy back....what have they got to loose.

[the canadian mounted] 10/4/2019 10:29

Cash equivalent to 75p a share alone!